Skip to main navigation Skip to search Skip to main content

Taxanes: A new class of antitumor agents

  • M. T. Huizing*
  • , V. H. Sewberath Misser
  • , R. C. Pieters
  • , W. W. ten Bokkel Huinink
  • , C. H. N. Veenhof
  • , J. B. Vermorken
  • , H. M. Pinedo
  • , J. H. Beijnen
  • *Corresponding author for this work
  • Slotervaart Hospital
  • Netherlands Cancer Institute
  • Amsterdam UMC - University of Amsterdam
  • Amsterdam UMC - Vrije Universiteit Amsterdam

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Taxanes belong to a new group of antineoplastic agents with a novel mechanism of action for a cytotoxic drug. They promote microtubule assembly and stabilize the microtubules. Paclitaxel, the first agent in this group to become available, was isolated from the Pacific yew, Taxus brevifolia, in 1971. In preclinical and clinical studies, paclitaxel and its semisynthetic analog docetaxel exhibit significant antitumor activity. This review deals with the physicochemical properties, pharmacology, and results of preclinical and clinical trials of the taxanes. © 1995 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted.
Original languageEnglish
Pages (from-to)381-404
JournalCancer investigation
Volume13
Issue number4
DOIs
Publication statusPublished - 1995
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Taxanes: A new class of antitumor agents'. Together they form a unique fingerprint.

Cite this